Angiology
New findings from the United States, Taiwan and United Kingdom in the area of angiology described
Published in Blood Weekly, October 12th, 2006
Study 1: Acadesine is the first therapy proven to be effective for reducing the severity of acute postreperfusion myocardial infarction (MI) associated with coronary artery bypass graft (CABG) surgery.
According to a study from the United States, "The purpose of this study was to assess the safety and efficacy of the adenosine regulating agent (ARA) acadesine for reducing long-term mortality among patients with postreperfusion MI. No prospectively applied therapy exists that improves long-term survival after MI associated with CABG surgery-a robust model...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-10-12)
More Articles from Blood Weekly
- Blood Banking
Autologous blood transfusion storage condition effects are studied - Blood Safety
Cerus initiates Phase I clinical trial for Intercept blood system for red blood cells - Kidney Research
Study reveals that white blood cells can both hurt and help transplanted kidneys - Needlestick Injuries
Majority of needlestick injuries can be prevented - Anesthesia
Sevoflurane effects on cytokines in patients undergoing CABG are investigated - Angiology
Aggressive anticoagulation is not indicated for coronary artery bypass graft surgery - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
